The race is on for new treatments that stand up to omicron's explosive spread.
Pfizer’s Paxlovid is a series of 30 pills that can be taken at home over five days and is shown to reduce the risk of hospitalization from COVD-19 by nearly 90%.With omicron's explosive spread threatening to outpace currentThe first oral antiviral treatment for the virus wasWednesday. Pfizer's Paxlovid has proved effective against severe illness and death from COVID, and is expected to hold up against omicron.
Dr. Anthony Fauci, the nation's top infectious disease expert, said the low supply of sotrovimab is"something we need to worry about" in a private call this week between the White House COVID response team and the nation's governors obtained by ABC News.Dr. Aldo Calvo, medical director of Family Medicine at Broward Health, shows a Regeneron monoclonal antibody infusion bag during a news conference Thursday, Aug. 19, 2021 at the hospital in Fort Lauderdale, Fla.
Marcus Plescia, chief medical officer of the Association of State and Territorial Health Officials, told ABC News that state leaders gearing up for omicron face a multipronged challenge: what was a"compelling tool" against the virus is now compromised, and what now works is still in limited supply. In addition, with hospital staffing shortages, there are looming concerns that manpower to administer the treatment will also be scarce.
A spokeswoman for GSK told ABC News the company is"working with urgency and exploring options to expand our supply capacity in 2022," including securing additional batches of the ingredients they'll need to amp up sotrovimab manufacturing, and pushing up their next year supply plans to make more available sooner.
The government spent billions of dollars purchasing Regeneron and Eli Lilly's monoclonal antibody cocktail to ensure there would be enough supply; GSK's had not been as widely purchased and distributed. When delta became the dominant variant of concern and all three antibody therapies were effective against it, Eli Lilly's authorization was renewed.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Here’s Why Most Monoclonal Antibody Treatments Don't Work Against OmicronMost Monoclonal Antibody Treatments Don’t Work Against Omicron—Here’s Why
Read more »
Hospitals in New York region say they've run out of antibody treatment for omicron variantMajor hospitals in the New York region say they have stopped using monoclonal antibody therapies because they have run out of the treatment, leaving doctors without a vital tool for treating severely ill Covid patients.
Read more »
Hospitals in New York region say they've run out of antibody treatment for omicron variantMonoclonal antibodies, which are laboratory-made proteins that mimic the immune system’s mechanism for preventing the virus from entering healthy cells, have been used to treat patients at high risk of becoming severely ill from the coronavirus.
Read more »
What We Know So Far About Omicron COVID Variant SymptomsWhen pinpointing Omicron COVID variant symptoms, here's what we know, according to the CDC and WHO.
Read more »
NYC To Pay $100 To Recipients Of Booster Shot Amid Covid SurgeEvidence shows boosters are necessary to improve protection against infection from the omicron variant.
Read more »
Omicron symptoms: What we know about illness caused by the new variantOmicron variant symptoms may be different than previous Covid strains. Learn what you should know about Omicron symptoms and what to look out for.
Read more »